Skip to main content
MXCT
NASDAQ Life Sciences

MaxCyte to Buy Akron Bio, Expects Deal to Nearly Double Revenue Base

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$1.23
Mkt Cap
$134.168M
52W Low
$0.643
52W High
$1.805
52W Position info
91% above low
Off High info
32% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

MXCT sits 91% above its 52-week low of $0.643.

Summary

MaxCyte has agreed to acquire Akron Bio from Arcline Investment Management for $151.8 million, adding cell therapy manufacturing capabilities to its portfolio, and expects the deal to nearly double its revenue base. Akron Bio is expected to generate about $28 million in 2026 revenue. MaxCyte will pay $105 million in cash and 20.6 million shares at closing. That is a big claim for a company with a $134M market cap whose Q2 2026 revenue was $7.3M, down 15% year-over-year, before Q3 core revenue rebounded to about $8.1M, up 26%, with raised full-year guidance; Q3 revenue was $10.2M and the quarterly loss per share was 5c, with Q3 adjusted EBITDA of -5.1 million versus an IBES estimate of -7.99 million. The strategic logic is consolidation across cell therapy manufacturing. Watch whether the combined revenue run-rate matches the 'nearly double' framing.

At the time of this announcement, MXCT was trading at $1.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $134.2M. The 52-week trading range was $0.64 to $1.81. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

MXCT - Latest Insights

MXCT
Nov 10, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.19
Real-time Price: $1.11 info
Change: -$0.080 (-7%) info
Market Cap: $113.527M info
MXCT
Nov 10, 2026, 12:40 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1.16
Real-time Price: $1.11 info
Change: -$0.045 (-4%) info
Market Cap: $113.527M info
MXCT
Nov 10, 2026, 8:21 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.36
Real-time Price: $1.11 info
Change: -$0.250 (-18%) info
Market Cap: $113.527M info
MXCT
Nov 10, 2026, 6:01 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.43
Real-time Price: $1.11 info
Change: -$0.320 (-22%) info
Market Cap: $113.527M info
MXCT
Oct 14, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $1.11 info
Change: +$0.110 (+11%) info
Market Cap: $113.527M info